- Home
- NTHI vs BYFC Comparison
NTHI vs BYFC Comparison
Compare NTHI & BYFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NTHI | BYFC |
|---|---|---|
| Founded | 2008 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 106.0M | 90.3M |
| IPO Year | 2023 | 2013 |
Fundamental Metrics
Financial Performance| Metric | NTHI | BYFC |
|---|---|---|
| Price | $2.77 | $11.37 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $17.00 | N/A |
| AVG Volume (30 Days) | ★ 139.3K | 1.7K |
| Earning Date | 11-13-2026 | 07-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.07 |
| Revenue | $39,990.00 | ★ $184,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $160.29 |
| Revenue Growth | N/A | ★ 18.71 |
| 52 Week Low | $2.50 | $5.51 |
| 52 Week High | $12.00 | $12.35 |
Technical Indicators
Market Signals| Indicator | NTHI | BYFC |
|---|---|---|
| Relative Strength Index (RSI) | 43.05 | 39.55 |
| Support Level | $2.50 | $9.29 |
| Resistance Level | $3.70 | $12.27 |
| Average True Range (ATR) | 0.25 | 0.14 |
| MACD | 0.03 | -0.06 |
| Stochastic Oscillator | 34.98 | 0.00 |
Price Performance
Historical ComparisonAbout NTHI NeOnc Technologies Holdings Inc.
NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.
About BYFC Broadway Financial Corporation
Broadway Financial Corp is active in the financial services domain. It is a savings and loan holding company in the United States. The Bank offers a variety of commercial real estate loan products, services, and depository accounts that support investments in affordable housing, small businesses, and nonprofit community facilities located within low-to-moderate income neighborhoods.